Stacy Newberry has Nurse Practitioner as her primary medical specialty. Their primary office is: 12697 E 51st St in Tulsa, Oklahoma.
They're a part of the: Oklahoma Cancer Specialists And Research Institute, Llc medical group which has around 49 members. You can call their office at 918-505-3200 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2018 (around 6 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
Stacy Newberry
Oklahoma Cancer Specialists And Research Institute, Llc
12697 E 51st St
Tulsa, Oklahoma 74146
918-505-3200
Phone: 918-505-3200
Enter a starting address:
Medical School: Sorry, her university is not listed
Graduation Year: 2018
The Primary Medical Specialty for Stacy Newberry is listed as: Nurse Practitioner
Approximate Years of Experience: 6
PAC (PECOS ID)#: 9133463060
NPI #: 1841775947
NPI Created On: 09/25/2018
NPI Last Updated Listed as: 09/25/2018
Primary Taxonomy Code: 363LG0600X
License Number:
R0055982
Listed Gender: Female
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $19
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest:
Third party is a Charity:: No
Record ID:: 788745681
Being Disputed:: No
Product Related: No
Payments Total: $14
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest:
Third party is a Charity:: No
Record ID:: 788745683
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $19
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest:
Third party is a Charity:: No
Record ID:: 788745685
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest:
Third party is a Charity:: No
Record ID:: 788745687
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $14
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 819415359
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: CYRAMZA
Open Associated Drug #1: 0002-7669-01
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: RETEVMO
Associated Drug #2: 0002-2980-60
Payments Total: $16
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest:
Record ID:: 832187547
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: PADCEV
Open Associated Drug #1: 51144-030-01
Payments Total: $13
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest:
Record ID:: 832187567
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: PADCEV
Open Associated Drug #1: 51144-030-01
Payments Total: $20
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest:
Record ID:: 832187611
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: ADCETRIS
Open Associated Drug #1: 51144-050-01
Payments Total: $17
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Ownership Interest:
Record ID:: 783698421
Being Disputed:: No
Product Related: Yes
Payments Total: $17
Number of Payments:: 1
Form of Payment: Cash or cash equivalent
Ownership Interest:
Record ID:: 783518159
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Hematology
Name of Drug #1: REBLOZYL
Open Associated Drug #1: 59572-711-01
1265 S Utica Ave
Tulsa, OK
Ahs Oklahoma Heart Llc
9228 S Mingo Rd
Tulsa, OK
Ahs Oklahoma Heart Llc
6161 S Yale Ave
Tulsa, OK
Warren Clinic Inc
10109 E 79th St
Tulsa, OK
Creek Nation Hospital And Clinics
5110 S Yale Ave
Tulsa, OK
Orthopedic And Trauma Service Of Oklahoma, Pc
1623 S Utica Ave
Tulsa, OK
Select Physical Therapy Holdings Inc
901 N Strong Blvd
Mcalester Ok 74501-4206
Oklahoma Cancer Specialists And Research Institute, Llc
Nurse Practitioner
12697 E 51st St
Tulsa Ok 74146-6236
Oklahoma Cancer Specialists And Research Institute, Llc
Nurse Practitioner
800 W Boise Cir
Broken Arrow Ok 74012-4974
Oklahoma Cancer Specialists And Research Institute, Llc
Dermatology
12697 E 51st St
Tulsa Ok 74146-6236
Oklahoma Cancer Specialists And Research Institute, Llc
Medical Oncology
12697 E 51st St
Tulsa Ok 74146-6236
Oklahoma Cancer Specialists And Research Institute, Llc
Nurse Practitioner
3470 E Frank Phillips Blvd
Bartlesville Ok 74006-2406
Oklahoma Cancer Specialists And Research Institute, Llc
Nurse Practitioner
View all 49 members of Oklahoma Cancer Specialists And Research Institute, Llc medical group